• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2200274 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2022-12-08 view
CXSS2000005 赛帕利单抗注射液 Zimberelimab Injection Biological Products(1) New Drug Application 2020-02-21 无锡药明生物技术股份有限公司,广州誉衡生物科技有限公司 Certificate Issued 2021-09-02 view
CXSL2300708 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-10-18 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CXSL2300709 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-10-18 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CYSB2200203 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2022-08-15 view
CXSL2300530 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-08-01 Guangzhou Gloria Biosciences Co Ltd view
CXSS2200025 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2022-03-15 view
CXSL2400475 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2024-07-24 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CXSL2300188 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2023-03-15 Gilead (Shanghai) Pharmaceutical Technology Co Ltd view
CXSL2200132 赛帕利单抗注射液 Zimberelimab Injection Biological Products(2.2) New Drug Application 2022-03-18 Guangzhou Gloria Biosciences Co Ltd view
CYSB2400017 赛帕利单抗注射液 Zimberelimab Injection Biological Products Supplementary Application 2024-01-17 view